Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11851426 Bicyclic amines as CDK2 inhibitors

Patent 11851426 was granted and assigned to Incyte on December, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 15 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11981671 Bicyclic pyrazolyl amines as CDK2 inhibitors
0
Edits on 27 Dec, 2023
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 27 Dec, 2023
Edits made to:
Infobox (+36 properties)
Article (+215 characters)
‌

 US Patent 11851426 Bicyclic amines as CDK2 inhibitors

Article

Patent abstract

The present application provides bicyclic amines that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118514260
Patent Inventor Names
Ding-Quan Qian0
Liangxing Wu0
Sarah Winterton0
Wenqing Yao0
Yingda Ye0
Zhenwu Li0
Date of Patent
December 26, 2023
0
Patent Application Number
170672030
Date Filed
October 9, 2020
0
Patent Citations
‌
US Patent 7101663 PCR method
0
‌
US Patent 7488802 Antibodies against PD-1
0
‌
US Patent 7820665 Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
0
‌
US Patent 7897572 Theraputic methods for type I diabetes
0
‌
US Patent 7943743 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
0
‌
US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
0
‌
US Patent 8168757 PD-1 binding proteins
0
‌
US Patent 8183242 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
0
‌
US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture
0
‌
US Patent 8431596 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
0
‌
US Patent 8865732 Heterocyclic compounds and uses thereof
0
‌
US Patent 9073927 Inhibitors of PI3 kinase
0
‌
US Patent 9850244 Method for preparing Palbociclib
0
‌
US Patent 10308644 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11066404 Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
0
‌
US Patent 11384083 Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
0
‌
US Patent 11427567 Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors
0
‌
US Patent 11440914 Tricyclic amine compounds as CDK2 inhibitors
0
‌
US Patent 11447494 Tricyclic amine compounds as CDK2 inhibitors
0
‌
US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
0
Patent Primary Examiner
‌
Susanna Moore
0
CPC Code
‌
C07D 471/04
0

Find more entities like US Patent 11851426 Bicyclic amines as CDK2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.